Cargando…
RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
BACKGROUND: As one of the most common malignancy, lung adenocarcinoma (LUAD) is characterized by low 5-year survival rate. This research aimed to investigate the effects of ribonucleotide reductase regulatory subunit M2 (RRM2) on malignant biological behaviors and activation of cGAS/STING pathway. W...
Autores principales: | Jiang, Xueping, Li, Yangyi, Zhang, Nannan, Gao, Yanping, Han, Linzhi, Li, Shuying, Li, Jiali, Liu, Xingyu, Gong, Yan, Xie, Conghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051110/ https://www.ncbi.nlm.nih.gov/pubmed/33858512 http://dx.doi.org/10.1186/s13578-021-00586-5 |
Ejemplares similares
-
Correction: RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma
por: Jiang, Xueping, et al.
Publicado: (2022) -
LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
por: Gao, Yanping, et al.
Publicado: (2022) -
SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
por: Zeng, Zihang, et al.
Publicado: (2022) -
Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells via Targeting HOXA10
por: Yuan, Cheng, et al.
Publicado: (2021) -
SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma
por: Li, Yangyi, et al.
Publicado: (2022)